nach oben

Der Nervenarzt

Erschienen in:

10.10.2023 | Klimawandel | Leitthema

Natur und Immunmechanismen psychischer Erkrankungen

verfasst von: Prof. Dr. Josef Priller, Simon Schäfer, Shima Safaiyan

Erschienen in: Der Nervenarzt | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Einflüsse der Natur und des Klimawandels auf die psychische Gesundheit sind erheblich. Allerdings sind die zugrunde liegenden Mechanismen bis heute kaum verstanden. Insbesondere dem Immunsystem wird eine wichtige Rolle beigemessen. Mithilfe moderner Modellsysteme will das Deutsche Zentrum für Psychische Gesundheit (DZPG) München den Beitrag des Immunsystems zur Entstehung psychischer Erkrankung unter veränderten Umweltbedingungen aufklären und präventive Behandlungsansätze entwickeln.

Albrecht G, Sartore GM, Connor L, Higginbotham N, Freeman S, Kelly B, Stain H, Tonna A, Pollard G (2007) Solastalgia: the distress caused by environmental change. Australas Psychiatry 15(Suppl 1):S95–S98PubMedCrossRef

Krüger T, Kraus T, Kaifie A (2022) A changing home: a cross-sectional study on environmental degradation, resettlement and psychological distress in a Western German coal-mining region. Int J Environ Res Public Health 19(12):7143PubMedCrossRefPubMedCentral

Testoni I, Mauchigna L, Marinoni GL, Zamperini A, Bucuță M, Dima G (2019) Solastalgia’s mourning and the slowly evolving effect of asbestos pollution: a qualitative study in Italy. Heliyon 5(12):e3024PubMedCrossRefPubMedCentral

Canu WH, Jameson JP, Steele EH, Denslow M (2017) Mountaintop removal coal mining and emergent cases of psychological disorder in Kentucky. Community Ment Health J 53(7):802–810PubMedCrossRef

Ellis NR, Albrecht GA (2017) Climate change threats to family farmers’ sense of place and mental wellbeing: a case study from the Western Australian Wheatbelt. Soc Sci Med 175:161–168PubMedCrossRef

Graham H, White P, Cotton J, McManus S (2019) Flood- and weather-damaged homes and mental health: an analysis using England’s mental health survey. Int J Environ Res Public Health 16(18):3256PubMedCrossRefPubMedCentral

To P, Eboreime E, Agyapong VIO (2021) The impact of wildfires on mental health: a scoping review. Behav Sci 11(9):126PubMedCrossRefPubMedCentral

Lehmann F, Alary PE, Rey G, Slama R (2022) Association of daily temperature with suicide mortality: a comparison with other causes of death and characterization of possible attenuation across 5 decades. Am J Epidemiol 191(12):2037–2050PubMedCrossRef

He Y, Liu WJ, Jia N, Richardson S, Huang C (2023) Viral respiratory infections in a rapidly changing climate: the need to prepare for the next pandemic. Ebiomedicine 9:104593CrossRef

10.

Lee AS, Aguilera J, Efobi JA, Jung YS, Seastedt H, Shah MM, Yang E, Konvinse K, Utz PJ, Sampath V, Nadeau KC (2023) Climate change and public health: the effects of global warming on the risk of allergies and autoimmune diseases: the effects of global warming on the risk of allergies and autoimmune diseases. EMBO Rep 24(4):e56821PubMedCrossRef

11.

Bagath M, Krishnan G, Devaraj C, Rashamol VP, Pragna P, Lees AM, Sejian V (2019) The impact of heat stress on the immune system in dairy cattle: a review. Res Vet Sci 126:94–102PubMedCrossRef

12.

Rollins-Smith LA (2017) Amphibian immunity-stress, disease, and climate change. Dev Comp Immunol 66:111–119PubMedCrossRef

13.

Falkai P, Koutsouleris N, Bertsch K, Bialas M, Binder E, Bühner M, Buyx A, Cai N, Cappello S, Ehring T, Gensichen J, Hamann J, Hasan A, Henningsen P, Leucht S, Möhrmann KH, Nagelstutz E, Padberg F, Peters A, Pfäffel L, Reich-Erkelenz D, Riedl V, Rueckert D, Schmitt A, Schulte-Körne G, Scheuring E, Schulze TG, Starzengruber R, Stier S, Theis FJ, Winkelmann J, Wurst W, Priller J (2022) Concept of the Munich/Augsburg consortium precision in mental health for the German center of mental health. Front Psychiatry 13:815718PubMedCrossRefPubMedCentral

14.

Stapelberg NJC, Bui TA, Mansour V, Johnson S, Branjerdporn G, Adhikary S, Ashton K, Taylor N, Headrick JP (2022) The pathophysiology of major depressive disorder through the lens of systems biology: network analysis of the psycho-immune-neuroendocrine physiome. J Neuroimmunol 372:577959PubMedCrossRef

15.

Dantzer R (2018) Neuroimmune interactions: from the brain to the immune system and vice vers. Physiol Rev 98(1):477–504PubMedCrossRef

16.

Sørensen NV, Frandsen BH, Orlovska-Waast S, Buus TB, Ødum N, Christensen RH, Benros ME (2023) Immune cell composition in unipolar depression: a comprehensive systematic review and meta-analysis. Mol Psychiatry 28(1):391–401PubMedCrossRef

17.

Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P (1998) Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 25(1 Suppl 1):39–47PubMed

18.

Cheslack-Postava K, Brown AS (2022) Prenatal infection and schizophrenia: a decade of further progress. Schizophr Res 247:7–15PubMedCrossRef

19.

Ursini G, Di Carlo P, Mukherjee S, Chen Q, Han S, Kim J, Deyssenroth M, Marsit CJ, Chen J, Hao K, Punzi G, Weinberger DR (2023) Prioritization of potential causative genes for schizophrenia in placenta. Nat Commun 14(1):2613PubMedCrossRefPubMedCentral

20.

Nani JV, Rodríguez B, Cruz FC, Hayashi MAF (2019) Animal models in psychiatric disorder studies. In: Eva T, Chandra YS (Hrsg) Animal models in medicine and biology. IntechOpen, Rijeka (Ch. 4)

21.

Kaiser T, Feng G (2015) Modeling psychiatric disorders for developing effective treatments. Nat Med 21(9):979–988PubMedCrossRefPubMedCentral

22.

Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13(10):1161–1169PubMedCrossRefPubMedCentral

23.

Cattane N, Vernon AC, Borsini A, Scassellati C, Endres D, Capuron L, Tamouza R, Benros ME, Leza JC, Pariante CM, Riva MA, Cattaneo A, European College of Neuropsychopharmacology (ECNP) ImmunoNeuroPsychiatry Thematic Working Group (2022) Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challenges. Eur Neuropsychopharmacol 58:55–79PubMedCrossRef

24.

Gradinaru V, Zhang F, Ramakrishnan C, Mattis J, Prakash R, Diester I, Goshen I, Thompson KR, Deisseroth K (2010) Molecular and cellular approaches for diversifying and extending optogenetics. Cell 141(1):154–165PubMedCrossRefPubMedCentral

25.

Belzung C, Lemoine M (2011) Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol Mood Anxiety Disord 1(1):9PubMedCrossRefPubMedCentral

26.

Ratsika A, Cruz Pereira JS, Lynch CMK, Clarke G, Cryan JF (2023) Microbiota-immune-brain interactions: a lifespan perspective. Curr Opin Neurobiol 78:102652PubMedCrossRef

27.

Gibney SM, Drexhage HA (2013) Evidence for a dysregulated immune system in the etiology of psychiatric disorders. J Neuroimmune Pharmacol 8(4):900–920PubMedCrossRef

28.

Bennett FC, Molofsky AV (2019) The immune system and psychiatric disease: a basic science perspective. Clin Exp Immunol 197(3):294–307PubMedCrossRefPubMedCentral

29.

Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179(2):292–311PubMedCrossRef

30.

Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46–56PubMedCrossRefPubMedCentral

31.

Orsal AS, Blois SM, Bermpohl D, Schaefer M, Coquery N (2008) Administration of interferon-alpha in mice provokes peripheral and central modulation of immune cells, accompanied by behavioral effects. Neuropsychobiology 58(3-4):211–222PubMedCrossRef

32.

Gibney SM, McGuinness B, Prendergast C, Harkin A, Connor TJ (2013) Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun 28:170–181PubMedCrossRef

33.

Ermakov EA, Melamud MM, Buneva VN, Ivanova SA (2022) Immune system abnormalities in schizophrenia: an integrative view and translational perspectives. Front Psychiatry 13:880568PubMedCrossRefPubMedCentral

34.

Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, Klein H, Steiner J, Frodl T, Bogerts B, Tian L, Groc L, Hasan A, Baune BT, Endres D, Haroon E, Yolken R, Benedetti F, Halaris A, Meyer JH, Stassen H, Leboyer M, Fuchs D, Otto M, Brown DA, Vincent A, Najjar S, Bechter K (2020) Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry 7(1):93–108 (Erratum in: Lancet Psychiatry. 2019 Dec;6(12):e31)PubMedCrossRef

35.

Winship IR, Dursun SM, Baker GB, Balista PA, Kandratavicius L, Maia-de-Oliveira JP, Hallak J, Howland JG (2019) An overview of animal models related to schizophrenia. Can J Psychiatry 64(1):5–17PubMedCrossRef

36.

Kneeland RE, Fatemi SH (2013) Viral infection, inflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 42:35–48PubMedCrossRef

37.

Meyer U (2014) Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75(4):307–315PubMedCrossRef

38.

Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE, Schizophrenia Working Group of the Psychiatric Genomics Consortium (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530(7589):177–183PubMedCrossRefPubMedCentral

39.

Duchatel RJ, Meehan CL, Harms LR, Michie PT, Bigland MJ, Smith DW, Jobling P, Hodgson DM, Tooney PA (2018) Increased complement component 4 (C4) gene expression in the cingulate cortex of rats exposed to late gestation immune activation. Schizophr Res 199:442–444PubMedCrossRef

40.

Handunnetthi L, Saatci D, Hamley JC, Knight JC (2021) Maternal immune activation downregulates schizophrenia genes in the foetal mouse brain. Brain Commun 3(4):fcab275PubMedCrossRefPubMedCentral

41.

Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26(3):383–392PubMedCrossRef

42.

Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ (2015) Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20(4):440–446PubMedCrossRef

43.

Zalcman SS (2002) Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D‑1 and D‑2 receptor antagonists. Brain Res 944(1-2):157–164PubMedCrossRef

44.

Smith SE, Li J, Garbett K, Mirnics K, Patterson PH (2007) Maternal immune activation alters fetal brain development through interleukin‑6. J Neurosci 27(40):10695–10702PubMedCrossRefPubMedCentral

45.

Tartaglione AM, Villani A, Ajmone-Cat MA, Minghetti L, Ricceri L, Pazienza V, De Simone R, Calamandrei G (2022) Maternal immune activation induces autism-like changes in behavior, neuroinflammatory profile and gut microbiota in mouse offspring of both sexes. Transl Psychiatry 12(1):384PubMedCrossRefPubMedCentral

46.

Birey F, Andersen J, Makinson CD, Islam S, Wei W, Huber N, Fan HC, Metzler KRC, Panagiotakos G, Thom N, O’Rourke NA, Steinmetz LM, Bernstein JA, Hallmayer J, Huguenard JR, Paşca SP (2017) Assembly of functionally integrated human forebrain spheroids. Nature 545(7652):54–59PubMedCrossRefPubMedCentral

47.

Bagley JA, Reumann D, Bian S, Lévi-Strauss J, Knoblich JA (2017) Fused cerebral organoids model interactions between brain regions. Nat Methods 14(7):743–751PubMedCrossRefPubMedCentral

48.

Schafer ST, Mansour AA, Schlachetzki JCM, Pena M, Ghassemzadeh S, Mitchell L, Mar A, Quang D, Stumpf S, Ortiz IS, Lana AJ, Baek C, Zaghal R, Glass CK, Nimmerjahn A, Gage FH (2023) An in vivo neuroimmune organoid model to study human microglia phenotypes. Cell 186(10):2111–2126.e20PubMedCrossRef

49.

Kathuria A, Lopez-Lengowski K, Jagtap SS, McPhie D, Perlis RH, Cohen BM, Karmacharya R (2020) Transcriptomic landscape and functional characterization of induced pluripotent stem cell-derived cerebral organoids in schizophrenia. JAMA Psychiatry 77(7):745–754PubMedCrossRefPubMedCentral

50.

Sawada T, Chater TE, Sasagawa Y, Yoshimura M, Fujimori-Tonou N, Tanaka K, Benjamin KJM, Paquola ACM, Erwin JA, Goda Y, Nikaido I, Kato T (2020) Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids. Mol Psychiatry 25(11):2695–2711PubMedCrossRefPubMedCentral

51.

de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH (2016) Advancing the understanding of autism disease mechanisms through genetics. Nat Med 22(4):345–361PubMedCrossRefPubMedCentral

52.

Nehme R, Barrett LE (2020) Using human pluripotent stem cell models to study autism in the era of big data. Mol Autism 11(1):21PubMedCrossRefPubMedCentral

Titel: Natur und Immunmechanismen psychischer Erkrankungen
verfasst von: Prof. Dr. Josef Priller
Simon Schäfer
Shima Safaiyan
Publikationsdatum: 10.10.2023
Verlag: Springer Medizin
Schlagwörter: Klimawandel
Psychosomatik
Affektive Störungen
Belastungs- und Anpassungsstörungen
Luftschadstoffe
Naturkatastrophen
Hitzewellen
Erschienen in: Der Nervenarzt / Ausgabe 11/2023
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI: https://doi.org/10.1007/s00115-023-01554-9

Passend zum Thema

Mittelgradige Depressionen & Johanniskraut: Das hat sich geändert

Affektive Störungen

Die Behandlungsempfehlungen bei mittelgradiger Depression wurden erneuert und der Einsatz von Johanniskraut entscheidend präzisiert – welche zwei Empfehlungen Sie aus der aktualisierten Depressions-Leitlinie jetzt kennen sollten.

3 Kernaussagen: Cochrane-Analyse untersucht Johanniskrautextrakte

Affektive Störungen

Johanniskraut gehört zu den am besten untersuchten pflanzlichen Arzneimitteln. Die Ergebnisse zur Wirksamkeit bei Depressionen wurden u. a. in einem Cochrane-Review analysiert [1]. Wie das pflanzliche Antidepressivum dabei abschnitt und welche drei Kernaussagen Sie für die Praxis kennen sollten, lesen Sie hier.

Depression behandeln. Natürlich.

Content Hub

Aktuelle Ergebnisse aus in-vitro- und in-vivo-Untersuchungen liefern detaillierte Erklärungen zum Wirkmechanismus von hochdosiertem Johanniskraut-Extrakt: Neu ist die Erkenntnis, dass der Johanniskraut-Extrakt bei chronischem Stress die deregulierte Stressantwort der überaktiven HPA-Achse sowie die Expression des Stressgens FKBP5 normalisieren kann. Mehr zum aktuellen Stand der Wissenschaft bei der Therapie von Depressionen erfahren Sie hier.

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2023

Personalisierte Psychotherapie der posttraumatischen Belastungsstörung

S3-Leitlinie Borderline-Persönlichkeitsstörung

Diagnostik & Therapie der Aufmerksamkeitsdefizit-Hyperaktivitäts-Störung im höheren Lebensalter

Mitteilungen der DGPPN 11/2023

Arbeit im Team und psychische Gesundheit

Die Bedeutung des humanen Mikrobioms für die psychische Gesundheit

Passend zum Thema

Mittelgradige Depressionen & Johanniskraut: Das hat sich geändert

3 Kernaussagen: Cochrane-Analyse untersucht Johanniskrautextrakte

Depression behandeln. Natürlich.